Etuvetidigene Autotemcel
14 interactions 1 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Lenacapavir Oral
Ibalizumab-Uiyk Injection
Lamivudine
Lenacapavir Injection
Fostemsavir
Maraviroc
Major
Etuvetidigene Autotemcel Abacavir Ziagen Explained An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Cabotegravir Apretude An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Didanosine Videx® An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Dolutegravir Juluca® (as a combination product containing dolutegravir, rilpivirine) An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Doravirine Pifeltro An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Emtricitabine Emtriva An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Enfuvirtide Injection Fuzeon An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Fostemsavir Rukobia An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Ibalizumab-Uiyk Injection Trogarzo An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Lamivudine Epivir An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Lenacapavir Injection Sunlenca An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Lenacapavir Oral Sunlenca An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Maraviroc Selzentry An increased risk of interference with the manufacturing of etuvetidigene autotemcel Details Etuvetidigene Autotemcel Nevirapine Viramune An increased risk of interference with the manufacturing of etuvetidigene autotemcel DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.